When diagnosed with a disease, it’s often overwhelming to sort through mountains of medical data to figure out what therapies are available, pinpoint where they’re offered and identify the best experts to help. Complexity specialist Gunjan Bhardwaj recognizes that mining this information may best be done using a system of artificial intelligence and blockchain to help people, within and outside the medical field, navigate and comprehend such “deep, dense and diverse” data — entering a new era where all research is searchable and shareable.
Gunjan Bhardwaj studied at IIT Bombay, FH Pforzheim, MIT Sloan and EBS Oestrich-Winkel. He founded Innoplexus in 2011, a technology and product development company focused on solving challenges in life sciences and pharmaceuticals using artificial intelligence. Previously, he worked for BCG and EY. He has authored numerous articles for the Harvard Business Review, the MIT Sloan Review and other journals, and has advised businesses and nonprofit organizations. He lectures at the Frankfurt School of Finance and other schools.
Innoplexus, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others
Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in the sum of double-digit millions. The round was co-led by FinLab EOS VC Fund, a venture capital fund backed by both Block.one, the publisher of the blockchain protocol EOSIO, and FinLab AG, one of Europe’s largest company builders and investors focused on financial services technologies. The FinLab EOS VC Fund invests across sectors and focuses on projects delivering value through the application of the EOSIO blockchain technology. Innoplexus AG represents FinLab EOS VC Fund’s largest investment to date.
Co-lead investor was existing shareholder ATAI Life Sciences, a global biotech company builder focused on developing breakthrough innovations in mental health. Innoplexus and ATAI closely cooperate to make the drug development process in mental health more effective and efficient by utilizing Innoplexus’ technology.
Innoplexus will use the funding to continue developing its AI and blockchain solutions and for international commercial expansion. “We are pleased to have gained yet another strong investor with the FinLab EOS VC Fund, who will support us to scale even further with their know-how and network,” says Dr. Gunjan Bhardwaj, Founder and CEO of Innoplexus.
Innoplexus’ products & solutions are used by global pharmaceutical and biotechnology companies as well as Clinical Research Organizations generating actionable insights across the drug development life cycle. The company is ushering in a new paradigm in drug discovery and development with its domain specific AI. Innoplexus is working with cutting edge technologies related to information retrieval, network analysis, computer vision, entity normalization and ontologies and has a strong focus on creating proprietary intellectual property.
“We fully believe in the mission of Innoplexus and will support them in transforming drug discovery and development into the areas of AI and blockchain. By integrating the EOSIO protocol, meaningful unpublished data could also be used for research. Innoplexus is leveraging the EOSIO blockchain to integrate unpublished data, as well as information that is trapped in silos, to aggregate growing data oceans and to accelerate drug discovery and development,’’ shares Juan Rodriguez, Managing Director of FinLab EOS VC Fund.
Image Credit: Innoplexus
News This Week
DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that’s reshaping industries [...]
These startups have seen investment from NEA, Andreessen Horowitz, and DARPA, among many others. As the digital health sector matures from basic tracking apps into highly regulated medical devices, we are seeing bleeding edge [...]
Quantum technologies utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing. However [...]
Nanoparticles can be used in many ways as catalysts. To be able to tailor them in such a way that they can catalyse certain reactions selectively and efficiently, researchers need to determine the properties [...]
University of Copenhagen researchers have developed a nanocomponent that emits light particles carrying quantum information. Less than one-tenth the width of a human hair, the miniscule component makes it possible to scale up [...]
Once cartilage is damaged, there is little that can be done to repair it. Unlike many other tissues, cartilage doesn’t heal well and consequences of injuries and disease can last a lifetime. Now [...]
Bacteria across our planet contain nanometer-sized factories that do many different things. Some make nutrients, others isolate toxic materials that could harm the bacteria. We have barely scratched the surface of their functional diversity. [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - May 2 2019 Since [...]
Researchers from University of Jyväskylä and Aalto University in Finland have developed a customized DNA nanostructure that can perform a predefined task in human body-like conditions (ACS Nano, "Reconfigurable DNA Origami Nanocapsule for pH-Controlled [...]
Some of the most famous scientific discoveries happened by accident. From Teflon and the microwave oven to penicillin, scientists trying to solve a problem sometimes find unexpected things. This is exactly how we created [...]
When diagnosed with a disease, it's often overwhelming to sort through mountains of medical data to figure out what therapies are available, pinpoint where they're offered and identify the best experts to help. Complexity [...]
The NanoMedicines Innovation Network (NMIN) has been awarded $18.5 million in new funding from the Networks of Centres of Excellence (NCE), a federal program that connects teams of scientists across Canada to collaborate on [...]
Young researchers from Siberian Federal University (SibFU) along with their colleagues from FRC KSC SB RAS are designing a technology for producing multilayer gilded nanodisks for targeted drug delivery and treating cancer using dip [...]
Frank Boehm: Publication of our new paper “Human Brain/Cloud Interface” in Frontiers in Neuroscience
Contributors: Nuno R. B. Martins, Amara Angelica, Yuriy Svidinenko, Frank J. Boehm, Ioan Opris, Mikhail A. Lebedev, Melanie Swan, Steven A. Garan, Jeffrey V. Rosenfeld, Tad Hogg, Robert A. Freitas Jr. et al Excerpt [...]
Abstract The progressive growth in nanotechnology approaches to diagnostics and therapeutics, especially for cancer, necessitates training physicians in nanoethics. This article explains why it is critical for medical education to include instruction in [...]